Appendiceal cancer is a rare cancer without standardized screening guidelines, risk factors or tumor classifications—a situation that often results in late diagnosis and poor prognosis.

Scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal neighborhood -- known as the tertiary lymphoid structure -- where they become ...

Cleveland Clinic researchers are three years into a longitudinal brain study, in which volunteers are undergoing periodic medical imaging, cognitive assessments and neuropsychological exams to help ...

The U.S. Food and Drug Administration (FDA) has approved vimseltinib (RomvimzaTM) for adult patients with a rare condition called tenosynovial giant cell tumor (TGCT). TGCT is a tumor of the tissue ...